Hippocampal Excitatory Synaptic Transmission and Plasticity Are Differentially Altered during Postnatal Development by Loss of the X-Linked Intellectual Disability Protein Oligophrenin-1

Cells. 2022 May 5;11(9):1545. doi: 10.3390/cells11091545.

Abstract

Oligophrenin-1 (OPHN1) is a Rho-GTPase-activating protein (RhoGAP), whose mutations are associated with X-linked intellectual disability (XLID). OPHN1 is enriched at the synapse in both pre- and postsynaptic compartments, where it regulates the RhoA/ROCK/MLC2 signaling pathway, playing a critical role in cytoskeleton remodeling and vesicle recycling. Ophn1 knockout (KO) adult mice display some behavioral deficits in multiple tasks, reminiscent of some symptoms in the human pathology. We also previously reported a reduction in dendritic spine density in the adult hippocampus of KO mice. Yet the nature of the deficits occurring in these mice during postnatal development remains elusive. Here, we show that juvenile KO mice present normal basal synaptic transmission, but altered synaptic plasticity, with a selective impairment in long-term depression, but no change in long-term potentiation. This contrasts with the functional deficits that these mice display at the adult stage, as we found that both basal synaptic transmission and long-term potentiation are reduced at later stages, due to presynaptic alterations. In addition, the number of excitatory synapses in adult is increased, suggesting some unsuccessful compensation. Altogether, these results suggest that OPHN1 function at synapses is differentially affected during maturation of the brain, which provides some therapeutic opportunities for early intervention.

Keywords: Oligophrenin-1; development; hippocampus; intellectual disability; plasticity; synaptic transmission.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytoskeletal Proteins* / genetics
  • Cytoskeletal Proteins* / metabolism
  • GTPase-Activating Proteins* / genetics
  • GTPase-Activating Proteins* / metabolism
  • Hippocampus* / metabolism
  • Intellectual Disability* / genetics
  • Intellectual Disability* / pathology
  • Mice
  • Mice, Knockout
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Synaptic Transmission*

Substances

  • Cytoskeletal Proteins
  • GTPase-Activating Proteins
  • Nuclear Proteins
  • Ophn1 protein, mouse

Grants and funding

This work was funded by the French National Agency for Research (grant #ANR-15-CE16-0019-01) to P.B. and N.R., by the Jerome-Lejeune Foundation (grant #1415) to P.B., by the European Research Council (consolidator grant #683154), and the Jerome-Lejeune Foundation (grant #1535) to N.R.